Inventiva IVA
NASDAQ IVA
$4.78 -0.06 (-1.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Inventiva (IVA) Change in Acquisitions & Divestments (2021 - 2025)

Inventiva (IVA) posted quarterly Change in Acquisitions & Divestments of -$28.0 million for Q2 2025, down 388.97% year-over-year from $9.7 million in Q2 2024, and down 206.64% quarter-over-quarter from $26.3 million in Q4 2024.

Analysis

Inventiva (IVA) Change in Acquisitions & Divestments (2021 - 2025) Analysis & Trends

Inventiva's Change in Acquisitions & Divestments history runs 7 years deep, the most recent figure standing at -$28.0 million for Q2 2025.

  • In Q2 2025, Change in Acquisitions & Divestments fell 388.97% year-over-year to -$28.0 million; the TTM figure through Jun 2025 stood at -$14.2 million (down 246.04% YoY), while the FY2025 annual figure was -$154.6 million, down 688.68% from the prior year.
  • Change in Acquisitions & Divestments for Q2 2025 stood at -$28.0 million, down from $26.3 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $26.3 million in Q4 2024, with the low at -$28.0 million in Q2 2025.
  • The 5-year median for Change in Acquisitions & Divestments is $9.7 million (2023), against an average of $5.9 million.
  • The sharpest annual moves came in 2022 and 2025: Change in Acquisitions & Divestments surged 707.75% in 2022, then plunged 388.97% in 2025.
  • Inventiva's Change in Acquisitions & Divestments stood at $6.7 million in 2021, then jumped by 70.12% to $11.5 million in 2022, then slipped by 15.57% to $9.7 million in 2023, then soared by 171.22% to $26.3 million in 2024, then plunged by 206.64% to -$28.0 million in 2025.
  • Business Quant data shows IVA's Change in Acquisitions & Divestments at -$28.0 million in Q2 2025, $26.3 million in Q4 2024, and $9.7 million in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Inventiva 893.85 Mn 893.85 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -28.01 Mn
Dec 31, 2021 6.74 Mn
Jun 30, 2021 -1.89 Mn
Mar 31, 2021 9.00 Mn